243 related articles for article (PubMed ID: 25564369)
1. Assessing exposure to tobacco-specific carcinogen NNK using its urinary metabolite NNAL measured in US population: 2011-2012.
Wei B; Blount BC; Xia B; Wang L
J Expo Sci Environ Epidemiol; 2016; 26(3):249-56. PubMed ID: 25564369
[TBL] [Abstract][Full Text] [Related]
2. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in smokers in the United States: NHANES 2007-2008.
Xia Y; Bernert JT; Jain RB; Ashley DL; Pirkle JL
Biomarkers; 2011 Mar; 16(2):112-9. PubMed ID: 21114376
[TBL] [Abstract][Full Text] [Related]
3. Effect of differing levels of tobacco-specific nitrosamines in cigarette smoke on the levels of biomarkers in smokers.
Ashley DL; O'Connor RJ; Bernert JT; Watson CH; Polzin GM; Jain RB; Hammond D; Hatsukami DK; Giovino GA; Cummings KM; McNeill A; Shahab L; King B; Fong GT; Zhang L; Xia Y; Yan X; McCraw JM
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1389-98. PubMed ID: 20501750
[TBL] [Abstract][Full Text] [Related]
4. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.
Carmella SG; Borukhova A; Akerkar SA; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):113-20. PubMed ID: 9037562
[TBL] [Abstract][Full Text] [Related]
5. TSNA Exposure: Levels of NNAL Among Canadian Tobacco Users.
Czoli CD; Hammond D
Nicotine Tob Res; 2015 Jul; 17(7):825-30. PubMed ID: 25481919
[TBL] [Abstract][Full Text] [Related]
6. Carcinogen Exposure among Canadian Tobacco Users: Changes in NNK Exposure from 2007-2009 through 2012-2013.
Czoli CD; Hammond D
Cancer Epidemiol Biomarkers Prev; 2018 Mar; 27(3):262-267. PubMed ID: 29358222
[No Abstract] [Full Text] [Related]
7. Racial differences in exposure and glucuronidation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
Muscat JE; Djordjevic MV; Colosimo S; Stellman SD; Richie JP
Cancer; 2005 Apr; 103(7):1420-6. PubMed ID: 15726545
[TBL] [Abstract][Full Text] [Related]
8. Exposure to the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers from 3 populations with different risks of lung cancer.
Derby KS; Cuthrell K; Caberto C; Carmella S; Murphy SE; Hecht SS; Le Marchand L
Int J Cancer; 2009 Nov; 125(10):2418-24. PubMed ID: 19598261
[TBL] [Abstract][Full Text] [Related]
9. Direct analysis of tobacco-specific nitrosamine NNK and its metabolite NNAL in human urine by LC-MS/MS: evidence of linkage to methylated DNA lesions.
Hu CW; Hsu YW; Chen JL; Tam LM; Chao MR
Arch Toxicol; 2014 Feb; 88(2):291-9. PubMed ID: 24057573
[TBL] [Abstract][Full Text] [Related]
10. Uptake and metabolism of carcinogenic levels of tobacco-specific nitrosamines by Sudanese snuff dippers.
Murphy SE; Carmella SG; Idris AM; Hoffmann D
Cancer Epidemiol Biomarkers Prev; 1994; 3(5):423-8. PubMed ID: 7920210
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone to its biomarker total NNAL in smokeless tobacco users.
Hecht SS; Carmella SG; Stepanov I; Jensen J; Anderson A; Hatsukami DK
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):732-5. PubMed ID: 18349296
[TBL] [Abstract][Full Text] [Related]
12. Determination of tobacco-specific N-nitrosamines in urine of smokers and non-smokers.
Kavvadias D; Scherer G; Cheung F; Errington G; Shepperd J; McEwan M
Biomarkers; 2009 Dec; 14(8):547-53. PubMed ID: 19747086
[TBL] [Abstract][Full Text] [Related]
13. Exposure to different sources of second-hand smoke during pregnancy and its effect on urinary cotinine and tobacco-specific nitrosamine (NNAL) concentrations.
Vardavas CI; Fthenou E; Patelarou E; Bagkeris E; Murphy S; Hecht SS; Connolly GN; Chatzi L; Kogevinas M
Tob Control; 2013 May; 22(3):194-200. PubMed ID: 22253001
[TBL] [Abstract][Full Text] [Related]
14. Tobacco-Specific Nitrosamines (NNAL, NNN, NAT, and NAB) Exposures in the US Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014).
Xia B; Blount BC; Guillot T; Brosius C; Li Y; Van Bemmel DM; Kimmel HL; Chang CM; Borek N; Edwards KC; Lawrence C; Hyland A; Goniewicz ML; Pine BN; Xia Y; Bernert JT; De Castro BR; Lee J; Brown JL; Arnstein S; Choi D; Wade EL; Hatsukami D; Ervies G; Cobos A; Nicodemus K; Freeman D; Hecht SS; Conway K; Wang L
Nicotine Tob Res; 2021 Feb; 23(3):573-583. PubMed ID: 32716026
[TBL] [Abstract][Full Text] [Related]
15. Metabolites of a tobacco-specific lung carcinogen in children exposed to secondhand or thirdhand tobacco smoke in their homes.
Thomas JL; Guo H; Carmella SG; Balbo S; Han S; Davis A; Yoder A; Murphy SE; An LC; Ahluwalia JS; Hecht SS
Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1213-21. PubMed ID: 21467230
[TBL] [Abstract][Full Text] [Related]
16. Urine cotinine underestimates exposure to the tobacco-derived lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in passive compared with active smokers.
Benowitz N; Goniewicz ML; Eisner MD; Lazcano-Ponce E; Zielinska-Danch W; Koszowski B; Sobczak A; Havel C; Jacob P
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2795-800. PubMed ID: 20805316
[TBL] [Abstract][Full Text] [Related]
17. Effect of maternal tobacco smoking or exposure to second-hand smoke on the levels of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine of mother and the first urine of newborn.
Florek E; Piekoszewski W; Basior A; Merritt AT; Mazela J; Lechowicz W; Kornacka MK; Kramer L
J Physiol Pharmacol; 2011 Jun; 62(3):377-83. PubMed ID: 21893699
[TBL] [Abstract][Full Text] [Related]
18. Extensive metabolic activation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers.
Stepanov I; Upadhyaya P; Carmella SG; Feuer R; Jensen J; Hatsukami DK; Hecht SS
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1764-73. PubMed ID: 18628430
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of a glucuronide conjugate of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in rats.
Atawodi SE; Michelsen K; Richter E
Arch Toxicol; 1994; 69(1):14-7. PubMed ID: 7717849
[TBL] [Abstract][Full Text] [Related]
20. Correlation between the urine profile of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolites and N7-methylguanine in urothelial carcinoma patients.
Lee HL; Hsueh YM; Chung CJ; Pu YS; Chang LW; Hsieh DP; Liou SH; Lin P
Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3390-5. PubMed ID: 19064555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
